Drug Pipeline News

Latest News

FDA grants New Drug Approval to enmetazobactam against cUTIs | Image Credit: © Araki Illustrations - © Araki Illustrations - stock.adobe.com.
FDA approves enmetazobactam for treatment of cUTIs

February 23rd 2024

Enmetazobactam (Exblifep; Orchid Pharma) gains FDA approval for treating complicated urinary tract infections in adults after demonstrating superiority over piperacillin-tazobactam in clinical cure and microbiological eradication in a global phase 3 trial.

FDA issues Complete Response Letter for cefepime-taniborbactam NDA | Image Credit: © JHVEPhoto - © JHVEPhoto - stock.adobe.com.
FDA issues Complete Response Letter for cefepime-taniborbactam NDA

February 23rd 2024

Nipocalimab granted Breakthrough Therapy Designation for HDFN | Image Credit: © Paulista - © Paulista - stock.adobe.com.
Nipocalimab granted Breakthrough Therapy Designation for HDFN

February 9th 2024

Oteseconazole outperforms fluconazole in treating severe vulvovaginal candidiasis | Image Credit: © Egor - © Egor - stock.adobe.com.
Oteseconazole outperforms fluconazole in treating severe vulvovaginal candidiasis

January 31st 2024

Contemporary OB/GYN week in review: RSV, elinzanetant, and more | Image Credit: © Aleksey 159 - © Aleksey 159 - stock.adobe.com.
Contemporary OB/GYN week in review: RSV, elinzanetant, and more

January 12th 2024

Video Interviews
Podcasts

More News

© 2024 MJH Life Sciences

All rights reserved.